Immunity for Health

IfH Symposium: Innovations in Antibody-Based Biologics

11 Jun 2026 | Landmark Building, UZ Brussels, Belgium

Register
Register
Register

Event agenda

Thursday, 11 June 2026

13:30 - 13:35

13:35 - 14:00

Antibody Horizons: Innovation, Translation and Clinical Impact – Hilde Revets, PHiRA Consulting/VUB

This talk gives an easy to understand look at how new antibody technologies are making treatments more precise and effective.

14:00 - 14:20

Bringing HER2 imaging to the clinic: from discovery to Phase 2b validation - Tony Lahoutte & Karine Clauwaert, UZ Brussels - Abscint

We share the development of ABSCINT’s HER2-targeted imaging platform, from concept to Phase 2b clinical validation in the HERMIA study. The results support its potential to reshape how HER2 expression is assessed and used in treatment decision-making.

2 speakers

14:20 - 14:32

Breaking Barriers: Delivering Biologicals to the Brain - Maarten Dewilde, KU Leuven

The limited number of biological therapies for central nervous system disorders is due to the blood–brain barrier, but recent breakthroughs are bringing a revolution within reach.

1 speaker

14:32 - 14:45

Intranasal convalescent plasma as prophylaxis against respiratory infections - Elise Wouters, Rode Kruis Vlaanderen

Intranasal convalescent plasma as prophylaxis against respiratory infections delivers antibody‑rich plasma directly to the upper respiratory mucosa to provide immediate, localized immune protection.

14:45 - 15:00

Q&A Session 1

A Q&A session with the session speakers, including questions from the audience, moderated by Prof. Niels Hellings - Hasselt University.

1 speaker

15:00 - 15:25

15:25 - 15:45

argenx's Immunology Innovation Program - Heleen Dewitte, argenx

Through innovation and fruitful partnership with academia, argenx has built a broad clinical development pipeline of differentiated antibody candidates that show promise in treating a variety of severe autoimmune and neurological disorders.

1 speaker

16:00 - 16:15

Beyond human health: mAb generation for companion animals - Markus Waldhuber, Zoetis

This presentation explores the unique challenges and opportunities in generating species-specific mAbs for veterinary use, bridging established human antibody engineering approaches with the emerging field of companion animal biologics.

1 speaker

16:15 - 16:30

Q&A Session 2

A Q&A session with the session speakers, including questions from the audience, moderated by Prof. Niels Hellings - Hasselt University.

1 speaker

16:30 - 17:30

Meetings

Networking

Location:
  • Reception Area

Meeting duration:15 minutes time slots